Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion

Immunobiology

Volumn 217, Issue 10, 2012, Pages 1017-1024

  Tel, Jurjen ^a   Beenhakker, Niels ^b   Koopman, Gerrit ^b   Hart, Bert't ^b   Mudde, Geert C ^c   de Vries, I Jolanda M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c S TARget Therapeutics GmbH   (Austria)

Author keywords

Allergy; CD32a; CpG ODN; Plasmacytoid dendritic cell; Targeting

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; FC RECEPTOR IIA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HAPLORHINI; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NONHUMAN; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BIOTINYLATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-ALPHA; MACACA MULATTA; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, FC; RECEPTORS, IGG; TOLL-LIKE RECEPTOR 9;

EID: 84865400516     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.01.016     Document Type: Article

References (51)

1. Asselin-Paturel C., Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J. Exp. Med. 2005, 202:461.
2. Benitez-Ribas D., Adema G.J., Winkels G., Klasen I.S., Punt C.J., Figdor C.G., de Vries I.J. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake. J. Exp. Med. 2006, 203:1629.
3. Benitez-Ribas D., Tacken P., Punt C.J.A., de Vries I.J.M., Figdor C.G. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc{gamma}RII-mediated uptake of immune complexes and presentation by MHC class II. J. Immunol. 2008, 181:5219.
4. Benson M., Adner M., Cardell L.O. Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy?. Clin. Exp. Allergy 2001, 31:361.
5. Cao W., Rosen D.B., Ito T., Bover L., Bao M., Watanabe G., Yao Z., Zhang L., Lanier L.L., Liu Y.J. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 2006, 203:1399.
6. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5:1219.
7. Drutman S.B., Trombetta E.S. Dendritic cells continue to capture and present antigens after maturation in vivo. J. Immunol. 2010, 185:2140.
8. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., Gunther G., Johnston I., Lanzavecchia A., Nagasaka T., Okada T., Vermi W., Winkels G., Yamamoto T., Zysk M., Yamaguchi Y., Schmitz J. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 2001, 194:1823.
9. Dzionek A., Inagaki Y., Okawa K., Nagafune J., Rock J., Sohma Y., Winkels G., Zysk M., Yamaguchi Y., Schmitz J. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum. Immunol. 2002, 63:1133.
10. Farkas L., Kvale E.O., Johansen F.E., Jahnsen F.L., Lund-Johansen F. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J. Allergy Clin. Immunol. 2004, 114:436.
11. Fili L., Ferri S., Guarna F., Sampognaro S., Manuelli C., Liotta F., Cosmi L., Matucci A., Vultaggio A., Annunziato F., Maggi E., Guarna A., Romagnani S., Parronchi P. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. J. Allergy Clin. Immunol. 2006, 118:511.
12. Fuchs A., Cella M., Kondo T., Colonna M. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 2005, 106:2076.
13. Grewe M., Walther S., Gyufko K., Czech W., Schopf E., Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J. Invest. Dermatol. 1995, 105:407.
14. Gupta G.K., Agrawal D.K. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma. BioDrugs 2010, 24:225.
15. Gursel M., Gursel I., Mostowski H.S., Klinman D.M. CXCL16 influences the nature and specificity of CpG-induced immune activation. J. Immunol. 2006, 177:1575.
16. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035.
17. Horner A.A., Raz E. Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J. Allergy Clin. Immunol. 2002, 110:706.
18. Hu Z., Sun S., Zhou F. The binding of CpG-oligodeoxynucleotides to cell-surface and its immunostimulatory activity are modulated by extracellular acidic pH. Vaccine 2003, 21:485.
19. Ito T., Amakawa R., Kaisho T., Hemmi H., Tajima K., Uehira K., Ozaki Y., Tomizawa H., Akira S., Fukuhara S. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 2002, 195:1507.
20. Ito T., Liu Y.J., Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int. J. Hematol. 2005, 81:188.
21. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001, 194:863.
22. Kandimalla E.R., Bhagat L., Yu D., Cong Y., Tang J., Agrawal S. Conjugation of ligands at the 5'-end of CpG DNA affects immunostimulatory activity. Bioconjug. Chem. 2002, 13:966.
23. Kline J.N., Kitagaki K., Businga T.R., Jain V.V. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L170.
24. Krieg A.M. CpG motifs: the active ingredient in bacterial extracts?. Nat. Med. 2003, 9:831.
25. Krishnamachari Y., Salem A.K. Innovative strategies for co-delivering antigens and CpG oligonucleotides. Adv. Drug Deliv. Rev. 2009, 61:205.
26. Maggi E. The TH1/TH2 paradigm in allergy. Immunotechnology 1998, 3:233.
27. Meyer-Wentrup F., Benitez-Ribas D., Tacken P.J., Punt C.J.A., Figdor C.G., de Vries I.J.M., Adema G.J. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-{alpha} production. Blood 2008, 111:4245.
28. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., Blazar B.R., Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 2004, 173:4433.
29. Mudde G.C., Van Reijsen F.C., Boland G.J., de Gast G.C., Bruijnzeel P.L., Bruijnzeel-Koomen C.A. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990, 69:335.
30. Mudde G.C., Bheekha R., Bruijnzeel-Koomen C.A. Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunol. Today 1995, 16:380.
31. Mudde G.C., Reischul I.G., Corvaia N., Hren A., Poellabauer E.M. Antigen presentation in allergic sensitization. Immunol. Cell Biol. 1996, 74:167.
32. Parronchi P., Maggi E., Romagnani S. Redirecting Th2 responses in allergy. Curr. Top. Microbiol. Immunol. 1999, 238:27.
33. Piccioli D., Sammicheli C., Tavarini S., Nuti S., Frigimelica E., Manetti A.G.O., Nuccitelli A., Aprea S., Valentini S., Borgogni E., Wack A., Valiante N.M. Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation. Blood 2009, 113:4232.
34. Platt C.D., Ma J.K., Chalouni C., Ebersold M., Bou-Reslan H., Carano R.A., Mellman I., Delamarre L. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4287.
35. Putta M.R., Zhu F.G., Wang D., Bhagat L., Dai M., Kandimalla E.R., Agrawal S. Peptide conjugation at the 5'-end of oligodeoxynucleotides abrogates toll-like receptor 9-mediated immune stimulatory activity. Bioconjug. Chem. 2010, 21:39.
36. Romagnani C., Della Chiesa M., Kohler S., Moewes B., Radbruch A., Moretta L., Moretta A., Thiel A. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur. J. Immunol. 2005, 35:2452.
37. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109.
38. Santamaria L.F., Bheekha R., van Reijsen F.C., Perez Soler M.T., Suter M., Bruijnzeel-Koomen C.A., Mudde G.C. Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum. Immunol. 1993, 37:23.
39. Schettini J., Mukherjee P. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin. Dev. Immunol. 2008, 2008:106321.
40. Schreibelt G., Tel J., Sliepen K.H., Benitez-Ribas D., Figdor C.G., Adema G.J., de Vries I.J. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol. Immunother. 2010, 59:1573.
41. Schroeder J.T., Bieneman A.P., Xiao H., Chichester K.L., Vasagar K., Saini S., Liu M.C. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J. Immunol. 2005, 175:5724.
42. Simons F.E., Shikishima Y., Van Nest G., Eiden J.J., HayGlass K.T. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J. Allergy Clin. Immunol. 2004, 113:1144.
43. Sinigaglia F., D'Ambrosio D., Rogge L. Type I interferons and the Th1/Th2 paradigm. Dev. Comp. Immunol. 1999, 23:657.
44. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9:271.
45. Tacken P.J., Zeelenberg I.S., Cruz L.J., van Hout-Kuijer M.A., van de Glind G., Fokkink R.G., Lambeck A.J., Figdor C.G. Targeted delivery of Toll-like receptor ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood 2011.
46. Tel J., Benitez-Ribas D., Hoosemans S., Cambi A., Adema G.J., Figdor C.G., Tacken P.J., de Vries I.J. DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur. J. Immunol. 2011, 41:1014.
47. Trinchieri G. Type I interferon: friend or foe?. J. Exp. Med. 2010, 207:2053.
48. Tulic M.K., Fiset P.O., Christodoulopoulos P., Vaillancourt P., Desrosiers M., Lavigne F., Eiden J., Hamid Q. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J. Allergy Clin. Immunol. 2004, 113:235.
49. Wenner C.A., Guler M.L., Macatonia S.E., O'Garra A., Murphy K.M. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 1996, 156:1442.
50. Yarovinsky F., Kanzler H., Hieny S., Coffman R.L., Sher A. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response. Immunity 2006, 25:655.
51. Yoneyama H., Matsuno K., Toda E., Nishiwaki T., Matsuo N., Nakano A., Narumi S., Lu B., Gerard C., Ishikawa S., Matsushima K. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 2005, 202:425.